Nader has to learn a lesson. It's all about credibility. He

New Post Public Reply Private Reply Replies (1) Message Board
Cytodynamite
551
Nader has to learn a lesson. It's all about credibility. He tends to have zero after the uncountable timelines being missed.

The result was the short attack. Followed by shareholders who lost faith.

I tried to make it clear from the very beginning. The science is only one aspect, being considered a trustworthy CEO is another.

No reason to sell, I accumulated in very low 80s. But Nader has to understand that imo.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials